Office of Research & Development |
|
Project Number: | I01CX001449-01A1 |
| Title: | Frequent, Low-Dose Erythropoietin: A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Therapy in Patients with Chronic Kidney Disease |
| Principal Investigator: | Mark S. Segal |
| Location: | Gainesville, FL |
| Congressional District Code: | 3 |
| Research Service: | Clinical Science R&D |
| Project Period: | October 2017 - September 2022 |
| FY 2022 Funding Amount: | $0 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |